Entegris, Inc. — Q2 2013 Form 10-Q
Business context and period: Entegris supplies products and services that purify, protect, and transport materials used in semiconductor and other high-technology manufacturing. This unaudited report covers the quarter ended June 29, 2013, and the six months then ended; comparisons are with the corresponding 2012 periods unless noted.
Financial results and liquidity
| Metric | Q2 2013 | Six months 2013 |
|---|---|---|
| Net sales | $177.5 million, down 6% | $342.6 million, down 6% |
| Gross profit / margin | $77.6 million / 43.7% (44.0% prior year) | $144.7 million / 42.2% (43.7% prior year) |
| Operating income / margin | $26.4 million / 14.9% | $46.6 million / 13.6% |
| Net income / diluted EPS | $19.8 million / $0.14 | $36.2 million / $0.26 |
| Operating cash flow | Not presented for quarter alone | $42.3 million |
| Capital expenditures | Not presented for quarter alone | $34.1 million |
At June 29, cash and cash equivalents were $343.4 million, versus cash and short-term investments totaling $350.4 million at year-end 2012. Working capital was $476.9 million. Entegris reported no short- or long-term debt; its $30 million revolving facility had no borrowings, with $0.2 million used for letters of credit. Total equity was $716.3 million.
Q2 sales rose 8% sequentially from Q1, and gross margin increased from 40.7% to 43.7%. For Q2, non-GAAP adjusted EBITDA was $36.1 million (20.3% margin), adjusted operating income was $28.7 million (16.2% margin), and non-GAAP diluted EPS was $0.15. These measures are company-defined and are not substitutes for GAAP results.
Changes and operating drivers
- Year-over-year sales weakness primarily reflected softer semiconductor-industry spending. Management described industry demand as mixed: leading-edge fabs were strong, but aggregate utilization remained below peak levels.
- Currency translation, primarily the weaker Japanese yen, reduced sales by $4.8 million in Q2 and $7.9 million in the first half. Excluding currency effects, sales declined 3% and 4%, respectively.
- Q2 segment sales/profit: Contamination Control Solutions (CCS) $114.6 million/$28.6 million; Microenvironments (ME) $45.9 million/$9.4 million; Specialty Materials (SMD) $17.0 million/$1.9 million. CCS and SMD sales and profits declined year over year; ME improved. SMD was affected by lower demand for high-margin coated products.
- Lower factory utilization and a less favorable sales mix weighed on year-over-year gross margin. Lower sales drove lower profit, partly offset by reduced SG&A and a lower tax rate. Six-month net income was down from $39.5 million to $36.2 million.
Outlook, risks, and notable items
- Management expected 2013 capital expenditures of approximately $60–$70 million, including about $40 million to complete a 450mm technology center and an advanced membrane and coatings facility. Capital purchase obligations were $20.4 million at June 29; the credit facility restricts annual capital expenditures to $85 million.
- Management believed cash, available credit, and operating cash flow would meet working-capital and investment needs for at least the next 12 months. About $140.2 million of cash was associated with foreign earnings considered indefinitely reinvested; repatriation may incur U.S. tax.
- On April 1, Entegris acquired Jetalon’s operating assets for $13.4 million cash plus contingent consideration of up to $14.5 million. A $3.1 million fair-value liability was recorded; the purchase-price allocation remained preliminary for certain intangible assets and contingent consideration.
- The first-half effective tax rate was 26.0%, versus 33.2% a year earlier; 2013 included a $1.3 million research-credit benefit. Q2 SG&A also included a $0.7 million reduction related to selling a building; sale proceeds were $6.5 million.
- Key risks include semiconductor-industry cyclicality, pricing and competition, fixed-cost absorption, foreign-exchange movements, and manufacturing and international risks. Ordinary-course legal matters were not expected by the company to have a material adverse effect. Management reported effective disclosure controls and no material quarterly change in internal control over financial reporting.
Important facts for investors to verify
- Whether semiconductor demand, utilization, and sequential sales improvement persisted after quarter-end, particularly in CCS and SMD.
- How much of reported sales and margin trends reflected currency, mix, and factory utilization, and whether the weaker yen continued to affect results.
- Actual capital spending against the $60–$70 million outlook, completion costs for planned facilities, and the $20.4 million purchase obligations.
- Final Jetalon intangible-asset valuations, subsequent contingent-consideration estimates, and the acquired business’s contribution.
- Cash-flow conversion and working-capital trends, including receivables and days sales outstanding, which rose to 56 days from 51 at year-end.
- Progress and remaining authorization under the 2013 share-repurchase program, and the availability and tax implications of foreign cash.